EZH2 and acute myeloid leukemia: Furthermore, miR profiling of AML-derived EVs revealed a distinct prolife, with deregulated miRs able to target known AML-related factors such as GSK-3β and Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit (EZH2) (62).